You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Details for Patent: 9,301,932


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,301,932 protect, and when does it expire?

Patent 9,301,932 protects ORFADIN and is included in one NDA.

This patent has twenty-four patent family members in twenty-two countries.

Summary for Patent: 9,301,932
Title:Liquid pharmaceutical composition comprising nitisinone
Abstract: The invention concerns a liquid pharmaceutical formulation suitable for oral administration, comprising a suspension of an effective amount of micronized 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (nitisinone); and citric acid buffer having a pH in the range of 2.5 to 3.5. The formulation is useful in the treatment of disorders and diseases in which inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) is desirable, e.g. in hereditary tyrosinaemia type I.
Inventor(s): Svensson; Lennart (Solna, SE), Siden; Hans (Sollentuna, SE)
Assignee: SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB (Stockholm, SE)
Application Number:14/129,090
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 9,301,932

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Swedish Orphan ORFADIN nitisinone SUSPENSION;ORAL 206356-001 Apr 22, 2016 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y TREATMENT OF HEREDITARY TYROSINEMIA TYPE 1 (HT-1) IN COMBINATION WITH DIETARY RESTRICTION OF TYROSINE AND PHENYLALANINE ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,301,932

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden1150585Jun 23, 2011
PCT Information
PCT FiledJune 20, 2012PCT Application Number:PCT/SE2012/050681
PCT Publication Date:December 27, 2012PCT Publication Number: WO2012/177214

International Family Members for US Patent 9,301,932

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012273515 ⤷  Sign Up
Brazil 112013033008 ⤷  Sign Up
Canada 2838039 ⤷  Sign Up
Chile 2013003630 ⤷  Sign Up
China 103747781 ⤷  Sign Up
Cyprus 1117273 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.